Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 48 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatmentAdomako, A.; Calvo, V.; Biran, N.; Osman, K.; Chari, A.; Paton, J.; Paton, A.; Moore, K.; Schewe, D.; Aguirre-Ghiso, J.
2009Therapeutic strategies for Shiga toxin-producing Escherichia coli infectionsRogers, T.; Paton, A.
2008Decreased ER-associated degradation of alpha-TCR induced by Grp78 depletion with the SubAB cytotoxinLass, A.; Kujawa, M.; McConnell, E.; Paton, A.; Paton, J.; Wojcik, C.
2008Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxinByres, E.; Paton, A.; Paton, J.; Lofling, J.; Smith, D.; Wilce, M.; Talbot, U.; Chong, D.; Yu, H.; Huang, S.; Chen, X.; Varki, N.; Varki, A.; Rossjohn, J.; Beddoe, T.
2004Refinement of a therapeutic Shiga toxin-binding probiotic for human trialsPinyon, R.; Paton, J.; Paton, A.; Botten, J.; Morona, R.
2012BiP prevents rod opsin aggregationAthanasiou, D.; Kosmaoglou, M.; Kanuga, N.; Novoselov, S.; Paton, A.; Paton, J.; Chapple, J.; Cheetham, M.; Brodsky, J.L.
2010Structure, biological functions and applications of the AB5 toxinsBeddoe, T.; Paton, A.; Le Nours, J.; Rossjohn, J.; Paton, J.
2012Bioengineered microbes in disease therapyPaton, A.; Morona, R.; Paton, J.
2008Clathrin-dependent trafficking of subtilase cytotoxin, a novel AB(5) toxin that targets the endoplasmic reticulum chaperone BiPChong, D.; Paton, J.; Thorpe, C.; Paton, A.
2009Sab, a novel autotransporter of locus of enterocyte effacement-negative shiga-toxigenic escherichia coli O113:H21, Contributes to adherence and biofilm formationHerold, S.; Paton, J.; Paton, A.